DUBLIN--(BUSINESS WIRE)--The "Single-Use Bioprocessing Systems - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.
The Global Single-Use Bioprocessing Systems market is expected to grow from $2.12 billion in 2017 to reach $12.25 billion by 2026 with a CAGR of 19.1%.
Growing demand for biopharmaceuticals, growth in the production of monoclonal antibodies, rising adoption of disposable technologies and lower costs & lesser environmental impact of single-use bioprocessing technologies are some key factors propelling the market growth. However, issues interrelated to leachables and extractables and technical difficulties pertaining to large-scale bio-production are hampering the market.
Based on Product, bioreactors and fermenters witnessed significant growth due to numerous factors such as the development of R&D facilities of major pharmaceutical organizations, advanced acceptance of single-use technologies by CMOs and CROs producing biologics, and increase in buyer awareness regarding the benefits of single-use bioreactors.
- Thermo Fisher Scientific Inc.
- Merck Millipore
- Danaher Corporation
- 3M Company
- GE Healthcare
- Sartorius Stedim Biotech S.A.
- Applikon Biotechnology
- Finesse Solutions, Inc.
- Eppendorf AG
- Cesco Bioengineering Co. Ltd.
- Meissner Filtration Products, Inc.
- Parker Hannifin Corporation
- Saint Gobain
- Sentinel Process Systems
- Tarpon Biosystems Inc.
For more information about this report visit https://www.researchandmarkets.com/research/w6m2d8/singleuse?w=4